NN0519-0130

NN0519-0130 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NN0519-0130, covering 2025-12-31 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight [Phase 2]

See pricing